NCT04554134View on ClinicalTrials.gov

The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study

CompletedOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

January 1, 2015

Study Completion Date

February 1, 2020

Conditions
Coronary Disease
All Listed Sponsors
collaborator

Huai'an First People's Hospital

OTHER

collaborator

Changzhou No.2 People's Hospital

OTHER

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT04554134 - The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study | Biotech Hunter | Biotech Hunter